Hubungan Kadar Vitamin D dengan Derajat Keparahan Pasien COVID-19 Dewasa dan Lanjut Usia
DOI:
https://doi.org/10.55175/cdk.v49i7.265Keywords:
COVID-19, Kadar Vitamin D, prognosisAbstract
Latar Belakang: Populasi lanjut usia berisiko mengalami defisiensi vitamin D akibat beragam faktor, seperti kurangnya suplementasi dan gaya hidup, serta obesitas. COVID-19 merupakan penyakit infeksi dengan morbiditas dan mortalitas global. Beberapa studi terkait COVID-19, salah satunya meneliti potensi vitamin D sebagai proteksi terhadap COVID-19. Tujuan: Studi ini bertujuan untuk mengetahui hubungan kadar vitamin D dengan derajat keparahan pasien COVID-19 pada dewasa dan lanjut usia. Metode: Kami menelusuri database PubMed, Cochrane, EBSCOhost, dan Scopus untuk mencari dan menyaring studi dalam bentuk kohort. Selanjutnya beberapa artikel dengan isu serupa dianalisis menggunakan instrumen prognosis dari Oxford Centre for Evidence Based Medicine. Hasil: Didapatkan dua studi kohort prospektif yang lolos seleksi, yakni studi Baktash, dkk. (2020) dan Campi, dkk. (2021). Keduanya menunjukkan kadar vitamin D rendah berhubungan dengan prognosis klinis dan marka inflamasi yang lebih buruk pada kasus COVID-19 dewasa dan lanjut usia (p<0,05). Simpulan: Kadar vitamin D rendah berisiko marka inflamasi ataupun prognosis klinis lebih buruk pada pasien COVID-19 dewasa dan lanjut usia.
Background: Elderlies as well as adults are high-risk populations for vitamin D deficiency, caused by lack of supplementation, lifestyle, or obesity. COVID-19 is an infectious disease with global morbidity and mortality. Some studies showed vitamin D’s potential for protection against COVID-19. Objective: This evidencebased case report was to investigate the association between vitamin D levels with COVID-19 severity in adult and elderly patients. Method: Database such as PubMed, Cochrane, EBSCOHost, and Scopus were explored to search and filter relevant cohort studies. Articles with similar issue were analyzed with prognosis instrument from Oxford Centre for Evidence Based Medicine. Result: Two prospective cohort studies from Baktash, et al, (2020) and from Campi, et al, (2021) fulfilled the requirements. Both studies showed that low vitamin D levels was related to worse clinical prognosis and inflammation markers in COVID-19 cases (p<0.05). Conclusion: Low vitamin D levels were related to poorer clinical prognosis or COVID-19 inflammation markers in adult and elderly COVID-19 patients.
Downloads
References
Kementerian Kesehatan RI. Pedoman pencegahan dan pengendalian coronavirus disease (COVID-19) revisi ke-5. Kementerian Kesehatan RI; 2020.
Labetubun J. Weekly operational update on COVID-19:13.
Lee C, Choi WJ. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective. Arch Pharm Res. 2021;44(1):99–116.
Saponaro F, Saba A, Zucchi R. An update on vitamin D Metabolism. IJMS. 2020;21(18):6573.
Ebadi M, Montano-Loza AJ. Perspective: Improving vitamin D status in the management of COVID-19. Eur J Clin Nutr. 2020;74(6):856–9.
US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, et al. Screening for vitamin D deficiency in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(14):1436.
Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van den Abbeele K, et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. 2020;postgradmedj-2020-138712.
Campi I, Gennari L, Merlotti D, Mingiano C, Frosali A, Giovanelli L, et al. Vitamin D and COVID-19 severity and related mortality: A prospective study in Italy. BMC Infect Dis. 2021;21(1):566.
Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochemistr Mol Biol. 2020;203:105751.
Sabico S, Enani MA, Sheshah E, Aljohani NJ, Aldisi DA, Alotaibi NH, et al. Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid-19: A randomized clinical trial. Nutrients 2021;13(7):2170.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
